The authors of A further paper noted the administration of HBOT as adjuvant therapy for acute macular neuroretinopathy in systemic lupus erythematosus in conjunction with immunosuppression in two patients [11].Youn et al. [54] highlighted the lack of consensus in treating CRAO by way of a national study in America. The analyze surveyed directors of